Tripawd Talk Radio 130: In this inspiring episode of Tripawd Talk, we’re joined by Dr. Nicola Mason, a leading veterinary immunologist at the University of Pennsylvania, to discuss her groundbreaking work in treating osteosarcoma in dogs.
Dr. Mason explains how immunotherapy — specifically CAR T-cell therapy — is showing promise for dogs with metastatic bone cancer. You'll learn about a brand-new CAR iNKT cell therapy clinical trial using off-the-shelf donor immune cells to help dogs fight lung metastases after amputation and chemotherapy.
We also talk about the importance of immune system “fitness,” what researchers have learned from past clinical trials, and why the courage of pet parents participating in these studies is helping to advance care for both dogs and children with osteosarcoma.
Whether you’re facing a recent diagnosis or simply want to stay informed about the future of canine cancer care, this episode offers hope, insight, and valuable next steps.
GUEST BIO:
About Dr. Nicola Mason
Dr. Nicola Mason, BVetMed, PhD, DACVIM, FRCVS, is a professor of Professor of Medicine and Pathobiology at the University of Pennsylvania School of Veterinary Medicine. She a leading researcher in the field of veterinary immunotherapy.
Dr. Mason has pioneered groundbreaking cancer treatments for dogs, including immunotherapies that activate the body’s own immune system to fight osteosarcoma.
Her current research focuses on innovative cellular therapies, including CAR iNKT cell treatments designed to target metastatic disease. Dr. Mason’s work is helping shape the future of cancer care for both pets and people.
RESOURCES:
Mentioned in This Episode
New Clinical Trial at Penn Vet: Off-the-Shelf CAR T-Cell Therapy for Dogs with Osteosarcoma
https://tripawds.com/2025/07/17/penn-vet-clinical-trial-for-osteosarcoma-dogs/
Penn Vet Comparative Immunotherapy Program:
https://www.vet.upenn.edu/research/centers-laboratories/research-laboratory/clinical-immunotherapy
PBS Feature with Dr. Mason
Shelter Me: The Cancer Pioneers
https://www.pbs.org/video/the-cancer-pioneers-jemhoc/
AVMA Animal Health Studies Database: https://ebusiness.avma.org/aahsd/study_search.aspx
Connect & Learn More
Facing osteosarcoma? You’re not alone. The Tripawds Support Circle is here for you:
https://tripawds.circle.so
Stay updated with the latest in Tripawd news and research:
https://tripawds.com/subscribe
Subscribe to Tripawd Talk wherever you get your podcasts!
https://tripawds.com/radio
Learn more at tripawds.com. Join the free Tripawds Support Community at tripawds.circle.so. Help Tripawds everywhere at tripawds.org. Follow @tripawds on Facebook and @tripawdscommunity on Instagram.
Dateline NBC
Current and classic episodes, featuring compelling true-crime mysteries, powerful documentaries and in-depth investigations. Follow now to get the latest episodes of Dateline NBC completely free, or subscribe to Dateline Premium for ad-free listening and exclusive bonus content: DatelinePremium.com
Are You A Charlotte?
In 1997, actress Kristin Davis’ life was forever changed when she took on the role of Charlotte York in Sex and the City. As we watched Carrie, Samantha, Miranda and Charlotte navigate relationships in NYC, the show helped push once unacceptable conversation topics out of the shadows and altered the narrative around women and sex. We all saw ourselves in them as they searched for fulfillment in life, sex and friendships. Now, Kristin Davis wants to connect with you, the fans, and share untold stories and all the behind the scenes. Together, with Kristin and special guests, what will begin with Sex and the City will evolve into talks about themes that are still so relevant today. "Are you a Charlotte?" is much more than just rewatching this beloved show, it brings the past and the present together as we talk with heart, humor and of course some optimism.
Stuff You Should Know
If you've ever wanted to know about champagne, satanism, the Stonewall Uprising, chaos theory, LSD, El Nino, true crime and Rosa Parks, then look no further. Josh and Chuck have you covered.